Dr. Craig W. Carson, M.D.
Rheumatology (Rheumatology Physician)
- Medicare participating
At a glance
- Medical school
- University of Utah School of Medicine (1985)
- Years since graduation
- 41
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 998
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1985Medical school: University of Utah School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Rheumatology Physician primary
OK license 17781
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Benefis Hospitals Inc Great Falls, MT
Medical groups
- Oklahoma Arthritis Center, P.c. (45 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 998
- Services billed
- 155,428
- Patients’ average age
- 71
| Service | Times | Patients |
|---|---|---|
| Injection, tocilizumab, 1 mg | 194,304 | 81 |
| Injection, golimumab, 1 mg, for intravenous use | 192,635 | 313 |
| Injection, infliximab, excludes biosimilar, 10 mg | 60,845 | 258 |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 54,750 | 119 |
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 39,200 | 13 |
| Injection, ferric carboxymaltose, 1 mg | 36,950 | 29 |
| Injection, anifrolumab-fnia, 1 mg | 32,100 | 21 |
| Injection, romosozumab-aqqg, 1 mg | 30,660 | 44 |
| Injection, belimumab, 10 mg | 28,631 | 64 |
| Injection, denosumab, 1 mg | 12,421 | 161 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Edmond, OK | 388 |
| Hydroxychloroquine Sulfate Other prescribers in Edmond, OK | 185 |
| Oxycodone-Acetaminophen (oxycodone hcl/acetaminophen) Other prescribers in Edmond, OK | 168 |
| Pregabalin Other prescribers in Edmond, OK | 161 |
| Methotrexate (methotrexate sodium) Other prescribers in Edmond, OK | 138 |
| Tramadol Hcl Other prescribers in Edmond, OK | 115 |
| Oxycodone Hcl Other prescribers in Edmond, OK | 113 |
| Prednisone Other prescribers in Edmond, OK | 109 |
| Morphine Sulfate Er (morphine sulfate) Other prescribers in Edmond, OK | 87 |
| Celecoxib Other prescribers in Edmond, OK | 84 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 9 companies reported 71 payments worth $1,898 in total to this clinician.
| Amgen Inc. | $538 |
|---|---|
| Janssen Biotech, Inc. | $319 |
| AbbVie Inc. | $292 |
| AstraZeneca Pharmaceuticals LP | $254 |
| GlaxoSmithKline, LLC. | $240 |
| Novartis Pharmaceuticals Corporation | $120 |
| UCB, Inc. | $98.17 |
| Organon LLC | $21.81 |
| Food and Beverage | $1,898 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.